Accéder au contenu principal

avril 2024

Intra-Cellular Therapies

Intra-Cellular Therapies
US$575m
US Drapeau

Intra-Cellular Therapies

Co-Manager (Follow-On)
Healthcare Equity Capital Markets

Canaccord Genuity Acts as Co-Manager to Intra-Cellular Therapies on its US$575,000,049 Follow-On Offering